Google
BMRA — BIOMERICA INC (Healthcare >> Medical Devices)
BMRA FAQ
What is BMRA's P/E ratio?
BIOMERICA INC (BMRA) currently trades at a P/E ratio of 3,314.31.
What is BMRA's ROE?
BIOMERICA INC reports a Return on Equity (ROE) of -125.84%.
What is BMRA's dividend yield?
BIOMERICA INC offers a dividend yield of 0.00%.
What is BMRA's Deepscope Quality Score?
Deepscope rates BMRA's overall financial quality at 31 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy BMRA?
Deepscope's AI Timing Score for BMRA is 2 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does BMRA belong to?
BIOMERICA INC is classified under the Healthcare >> Medical Devices sector on the NASDAQ exchange.
|
USD 2.12
Price
-0.03
(-1.17%)
Day Change
|
|
|---|
BMRA, the overall quality is not good ( Quality = 31) and the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
P/E ratio is relatively high
ROE is relatively low.
ROA is relatively low.
Historical ROE is relatively low
Negative growth of ROE in the last year.
ROE is decreasing significantly
ROA is too relatively low compare to ROE
Growth of ROA was below our criteria in the last year.
Net profit margin is relatively low.
Historical net profit margin is relatively low.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not quite good , and ability to make profit is not quite good , ...
| Quality Factors |
|
45% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 88 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 2.12 |
| PBV / Sector |
2.00 / 7.50
|
| Earning Per Share | -1.33 |
| PE / Sector |
3,314.31 / 29.01
|
| PEG or PE/Growth / Sector |
19.09 / 0.39
|
| Average 1M Daily Value |
0.05 M
GREAT
|
| Average 1W Daily Value |
0.04 M
GREAT
|
| Timing Factors |
|
14% |
| Financial Health |
|
50% |
| Ability to Make Profit |
|
52% |
| Return to Investors |
|
4% |
| Registration Details |
| Analyze Date | 2026-06-06 09:08:28 |
| Symbol | BMRA |
| Name | BIOMERICA INC |
| Sector | Healthcare >> Medical Devices |
| Market | NASDAQ |
| Listed Shares | 3.09 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 6.63 / 18,389.26 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 17571 Von Karman Avenue, Irvine, CA, United States, 92614
Phone: 949 645 2111
Website: https://www.biomerica.com
Employees: 53
Sector: Healthcare >> Medical Devices
Description: Biomerica, Inc., a biomedical technology company, engages in developing, patenting, manufacturing, and marketing diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications, as well as to measure the levels of specific bacteria, hormones, antibodies, antigens, and other substances which may exist in the human body, stools, or blood in extremely small concentrations. It sells its products for treating gastrointestinal diseases and food intolerances, as well as various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also involved in the development of InFoods IBS, that uses a simple blood sample to identify patient-specific foods which may alleviate irritable bowel syndrome symptoms; and hp+detect, a H. Pylori diagnostic test that indicates if a patient is infected with the Helicobacter pylori bacteria. The company has strategic partnerships with Phoenix Airmid Biomedical and CanAlt Health Labs for launching the inFoods platform in Canada. Biomerica, Inc. was incorporated in 1971 and is headquartered in Irvine, California.
ME vs SECTOR Healthcare >> Medical Devices
Click a bubble to view stock details · Bubble size represents market capitalization share
